期刊
BLOOD
卷 133, 期 22, 页码 2359-2364出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2018-12-852830
关键词
-
类别
资金
- European Research Council [H2020-MSCA 765492, 713727, 336540]
- Netherlands Organisation for Scientific Research [91711366]
- Dutch Cancer Society [VU2015-8080]
- European Research Council (ERC) [713727] Funding Source: European Research Council (ERC)
Liquid biopsies have been considered the holy grail in achieving effective cancer management, with blood tests offering a minimally invasive, safe, and sensitive alternative or complementary approach for tissue biopsies. Currently, blood-based liquid biopsy measurements focus on the evaluation of biomarker types, including circulating tumor DNA, circulating tumor cells, extracellular vesicles (exosomes and oncosomes), and tumor-educated platelets (TEPs). Despite the potential of individual techniques, each has its own advantages and disadvantages. Here, we provide further insight into TEPs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据